(Q48796886)

15 February 2018

title

Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro. (English)

1 reference

15 February 2018

author name string

McGeer PL

1

1 reference

15 February 2018

Walker DG

2

1 reference

15 February 2018

Pitas RE

3

1 reference

15 February 2018

Mahley RW

4

1 reference

15 February 2018

McGeer EG

5

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

15 February 2018

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

15 February 2018

volume

749

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

135-138

1 reference

15 February 2018

Apolipoprotein E gene in Parkinson's disease with or without dementia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Regional Variation in the Distribution of Apolipoprotein E and Aβ in Alzheimerʼs Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Lipoprotein-receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Isolation and characterization of apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Apolipoprotein E and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901324-8

10.1016/S0006-8993(96)01324-8

7 January 2021

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

9070638

1 reference

15 February 2018